Special Issue "Epidemiology, Prognosis and Antimicrobial Treatment of Extensively Antibiotic-Resistant Bacterial Infections, 2nd Volume"
Deadline for manuscript submissions: 31 December 2023
https://www.mdpi.com/journal/antibiotics/special_issues/4H760OFK23
Special Issue Information
The first volume of the Special Issue "Epidemiology, Prognosis and Antimicrobial Treatment of Extensively Antibiotic-Resistant Bacterial Infections" was published in 2022. The topic of antimicrobial resistance remains important, with many gaps in the literature.
This second volume aims to complement the 2022 Special Issue and welcomes submissions that highlight current advances in the epidemiology, management and prognosis of infections by XDR/PDR bacteria, including XDR/PDR A. baumannii, P. aeruginosa (especially metallo-β-lactamase-producing P. aeruginosa), Enterobacterales and Stenotrophomonas maltophilia.
Topics may include but are not limited to:
- Epidemiology and mechanisms of resistance to new last-resort antimicrobials (e.g., cefiderocol or a combination of ceftazidime/avibactam with aztreonam);
- Heteroresistance and in vivo emergence of resistance against last-resort and new antimicrobials (and their impact on patient outcomes);
- Antimicrobial combinations (both in vitro and in vivo data are welcome) against XDR/PDR pathogens;
- Combination therapy vs. monotherapy against XDR bacteria;
- Comparative outcomes of infections by different XDR/PDR pathogens (e.g., XDR/PDR A. baumannii vs. XDR/PDR P. aeruginosa vs. XDR/PDR Enterobacterales);
- Systematic reviews and meta-analyses of comparative treatment efficiency against XDR/PDR pathogens;
- Case reports and case series of novel treatment options against infections by XDR/PDR pathogens;
- Population burden and public-health impact of infections by XDR/PDR bacteria;
- Clinical prediction models to guide antimicrobial treatment in infections caused by XDR/PDR bacteria.
Special Issue Editors
Dr. Stamatis Karakonstantis
Internal Medicine Department, Infectious Diseases Division, University Hospital of Heraklion, Heraklion, Greece
Interests: infectious diseases; infection control; antimicrobial resistance; antibiotic therapy; antibiotic stewardship; clinical epidemiology
Dr. Constantinos Tsioutis
School of Medicine, European University Cyprus, Nicosia, Cyprus
Interests: infection control; antimicrobial resistance; antimicrobial stewardship; medical education
Dr. Evangelos I. Kritsotakis
1. School of Medicine, University of Crete, Crete, Greece
2. School of Health and Related Research, University of Sheffield, Sheffield, UK
Interests: medical statistics; epidemiological methods; healthcare
epidemiology; infection control; antimicrobial resistance; public
health